Article Versions Notes

Chang C-Y, Wu K-L, Chang Y-Y, Liu Y-W, Huang Y-C, Jian S-F, Lin Y-S, Tsai P-H, Hung J-Y, Tsai Y-M, et al. The Downregulation of LSAMP Expression Promotes Lung Cancer Progression and Is Associated with Poor Survival Prognosis. Journal of Personalized Medicine. 2021; 11(6):578. https://doi.org/10.3390/jpm11060578

Chang, Chao-Yuan, Kuan-Li Wu, Yung-Yun Chang, Yu-Wei Liu, Yung-Chi Huang, Shu-Fang Jian, Yi-Shiuan Lin, Pei-Hsun Tsai, Jen-Yu Hung, Ying-Ming Tsai, and et al. 2021. "The Downregulation of LSAMP Expression Promotes Lung Cancer Progression and Is Associated with Poor Survival Prognosis" Journal of Personalized Medicine 11, no. 6: 578. https://doi.org/10.3390/jpm11060578

Chang, C.-Y., Wu, K.-L., Chang, Y.-Y., Liu, Y.-W., Huang, Y.-C., Jian, S.-F., Lin, Y.-S., Tsai, P.-H., Hung, J.-Y., Tsai, Y.-M., & Hsu, Y.-L. (2021). The Downregulation of LSAMP Expression Promotes Lung Cancer Progression and Is Associated with Poor Survival Prognosis. Journal of Personalized Medicine, 11(6), 578. https://doi.org/10.3390/jpm11060578